Product Details
| Product Name: Upadacitinib | CAS No.: 1310726-60-3 |
| EC-No.: 213-161-9 | Min. Order: 1Kg/Bag |
| Purity: 0.99 | Supply Ability: 20 tons |
| Release date: 2026/07/02 |
Product Information
| Name | Upadacitinib |
| Other names | Upadacitinib ABT-494 ABT-494(Upadacitinib) free base Upadacitinib (ABT-494) ABT-494 (Upadacitinib) Upadacitinib (Rinvoq) ABT-494 CS-2730 |
| Keywords | API |
| CAS NO. | 1310726-60-3 |
| Molecular Formula | C17H19F3N6O |
| Molecular Weight | 380.37g/mol |
What is Upadacitinib?
It is also being investigated as a potential treatment for people with active ankylosing spondylitis (AS). Upadacitinib
AS is an inflammatory, progressive autoimmune disease that affects the joints of the spine. As the disease progresses, calcium deposits form where ligaments attach to the bones that form the spine, leading to reduced flexibility of the back.
use Upadacitinib is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC50 of 43 nM.

Application
Upadacitinib function
Upadacitinib is a JAK1 selective inhibitor being investigated to treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, atopic dermatitis, psoriatic arthritis, axial SpA and Giant Cell Arteritis and Takayasu Arteritis.
Upadacitinib is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC50 of 43 nM.
Upadacitinib is a JAK1 selective inhibitor being investigated to treat rheumatoid arthritis, Crohn's disease, ulcerative colitis, atopic dermatitis, psoriatic arthritis, axial SpA and Giant Cell Arteritis and Takayasu Arteritis.
Company Information

Company Profile Introduction
You may like
-
CAS:1420477-60-6
-
CAS:39537-23-0
-
CAS:497-76-7
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $1.00 |
VIP8Y
|
.GZ HONESTCHEM CO.,LTD
|
2026-07-02 | |
|
VIP3Y
|
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
|
2026-07-02 | ||
|
VIP6Y
|
WUHAN FORTUNA CHEMICAL CO., LTD
|
2026-07-02 | ||
|
VIP2Y
|
Shaanxi Dideu New Materials Co. Ltd
|
2026-06-30 | ||
| $1.00 |
VIP2Y
|
S&Y Biochem Co.,Ltd
|
2026-06-29 | |
|
VIP3Y
|
Hangzhou Hyper Chemicals Limited
|
2026-05-29 | ||
| $300.00 |
VIP8Y
|
Anhui Dexinjia Biopharm Co., Ltd
|
2026-05-18 | |
|
VIP4Y
|
shandong perfect biotechnology co.ltd
|
2026-03-27 | ||
|
VIP4Y
|
Hangzhou ICH Biofarm Co., Ltd
|
2026-01-04 | ||
|
Wuhan Biocar Pharmacy CO.,Ltd.
|
2025-12-25 |
- Since: 1996-07-16
- Address: 16F,HUICHENG COMM,839 XIAHE ROAD,XIAMEN CHINA

China